APA Zitierstil

Garrido-Castro, A. C., Saura, C., Barroso-Sousa, R., Guo, H., Ciruelos, E., Bermejo, B., . . . Rodon, J. (2020). Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer. Breast Cancer Res.

Chicago Zitierstil

Garrido-Castro, Ana C., et al. "Phase 2 Study of Buparlisib (BKM120), a Pan-class I PI3K Inhibitor, in Patients With Metastatic Triple-negative Breast Cancer." Breast Cancer Res 2020.

MLA Zitierstil

Garrido-Castro, Ana C., et al. "Phase 2 Study of Buparlisib (BKM120), a Pan-class I PI3K Inhibitor, in Patients With Metastatic Triple-negative Breast Cancer." Breast Cancer Res 2020.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.